Development of the Novel Biologically Targeted Anticancer Agent
Development of the human cancer microRNA network Open Access
Development of Testing Criteria for Familial Breast/Ovarian Cancer
Development of targeted α therapy with Bi-213 and At-211
Development of systems biology methodology and software with
Development of Soft Tissue Sarcomas in Ribosomal Proteins L5 and
Development of services for symptomatic breast cancer
development of omics-based profiling tests for toxicology and
Development of novel cancer chemopreventive agents in Europe
Development of New Zealand tumour standards
Development of new protocol to expand T cells of better survival
Development of Inhalable Microparticles for Drug Delivery to Deep Lung Tissues
Development of high throughput technology to identify drugs for
Development of gene therapy to target pancreatic cancer
Development of Follow Up Guidelines for Upper GI Cancers
Development of Fibroblast Growth Factor Receptor
Development of cancer genetic services in the UK: A national
Development of cancer genetic services in the UK: A national
Development of cancer genetic services in the UK
Development of artemisinin compounds for cancer treatment Henry
